Sorry. My bad. Here is what I found so far it looks very encouraging.

positive result


Years of clinical trials have yeilded promising results for a vaccine that would protect women from a virus that causes colon and cervical cancer, researchers have said.

Four years after being vaccinated, 94 per cent of the 755 women who participated in the study were protected against the human variant of the papilloma virus 16 (HPV), according to a report presented at the American Society for Microbiology's world conference.

According to the study, only seven of the women were infected with the HPV virus, but none showed any precancerous symptoms.

In comparison, in the group of 750 women injected with a placebo, 111 were infected by the virus and 12 developed precancerous cells.

The research was financed by Merck pharmaceutical laboratories, which expects a green light from US government regulators to start the vaccine's production in 2005.

Colon and uterus cancer affects 500,000 women around the world each year and half of them die of the illness, researchers said.

British laboratories GlaxoSmithKline are also working on an anti-HPV vaccine, and is hoping for approval from US and British regulating agencies.